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In Caucasians the 2 "/-globulin genes Gmb and Gm  ~  are, as a rule, inherited together 
and form part of a  gene complex that appears to be aUelic to another complex with 
the  gene  Gm  a  (1-3).  No  Caucasian  myeloma globulins have been found  to contain 
the product of more than  1 of the 3 genes Gm  a, Gm  b, and Gra  ~ (2, 4). Precipitating 
anfisera  can  be used  to  distinguish  4  classes  of "/G-immunoglobulins  with  charac- 
teristic antigenic determinants  ascribable to the H(hcavy) polypeptide chains (5-7). 
It is postulated  that  each class corresponds  to  1 H  chain gene locus  (4);  that Gm* 
and  Gm* occur at  1 of these,  called the We locus after its antigenic  type, and  that 
Gmb occurs at the closely linked  Vi locus (1, 2, 4). 
Reagents that give the same results as the original anti-Gm(b) of Harboe (8) with 
almost  all  Caucasian  sera often  give discordant  results  with  sera  from other  races 
(9-11).  In other words, non-Caucasians  are often typed as positive with some, but 
not with  other,  "anti-Gin(b)"  reagents.  In a  study  of Japanese sera Ropartz et al. 
(9) found the anti-Gin(b) reagents to produce 3 different reaction patterns and named 
the  hereditary  factors  detected,  Gm(ba),  (b0),  and  (b~).  Steinberg and  Goldblum 
(10)  studied  populations  of different races and  used  the  designations  Gin(b1),  (b*), 
(bS), and  (b4). 
The various  Gin(b)  (9,  10)  and  Gin(f)  (1-3)  determinants  are all inherited 
together in Caucasians.  Investigations of myeloma and anti-Rh proteins  (2, 4) 
suggest that Gin(f) does not occur in the same -},-globulin molecules as certain 
Gin(b) determinants identical or closely related to Gm(b  ~) and (b  1) (11). How- 
ever  it  is not known whether  the other  Gin(b)  factors (e.g.,  b a, b e, b 2, b 8, and 
b *) are located on the same 7-globulin molecules as Gm(b  1) or Gin(f). The pur- 
pose  of  this  study  was  to  obtain  information  on  the  distribution  among  the 
"/-globulin  molecules,  primarily  through  the  use  of myeloma proteins,  of  the 
determinants identified by 18 anti-Gin(b)  and anti-Gm(f) reagents. 
Materials and Methods 
Reagents.--The anti-Gin sere used gave test systems that were inhibited  by Gin(+) sera 
diluted  1/100 or more, but not by Gin(--) sera even undiluted  (12). The origins and designa- 
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tions of the reagents are given in Table I. The reagents included: anti-Gin  (b~), (b~), and 
(b  x)  (9); the antLGm (b2), (b~), and (b  4) (10); and 5 anti-Gin (f) reagents (Table I). 
Mydom~z Glob~ins.--31 "yG-myeloma globulins which had been typed for Gm(a), (b), and 
(f)  (2, 4) were selected to comprise as many representatives as possible of the rare Gin(b+) 
type and of the less frequent H chain classes. All 31 were from American and Swedish patients; 
TABLE  I 
C-m Test Systems and Anti-C,m Reagents Used 
Anti-Gin(a) 
1.  B.A. 
2.  Stang. 
Anti-Gm(f) 
3.  Mau. c 
4.  A.J. 
5.  Lu.  b 
6.  Fi.  b 
7.  533802  d 
8.  Davis  h,  anti-b  ~ 
Anti-Gin  Anti-Rh 
Anti-Gin(b) 
9.  A.B.  ° 
10.  I.G.  anti-b~ 
11.  All.  g  anti-b~ 
12.  2247  f  anti-b~ 
13.  Caz.  g 
14.  Gar. 
15.  Th.  h  anti-b  a 
16a.  Bu.  h,  anti-b  4 
16b.  Bu.  h,  anti-b* 
17.  2357  f,  anti-bO 
18.  Let. g,  anti-b  ~ 
19.  114  ~ 
20.  2277  f,  anti-b  ~ 
602 
Roehm.  h 
TS.  b 
TS. 
2"6. 
TS. 
Roehm. 
m 
2127  t 
2127 
2127 
2127 
Vai. 
Vai. 
2127 
Vai. 
Vai. 
2127 
The sources of the anti-Gin reagents are indicated by the superscripts, s H. Fudenberg, 
San Francisco,  California, b W.  GShler, Leipzig,  Germany, e E.  R.  Gold, Bristol, England, 
d K.  L.  Goldsmith,  London,  England,  e M.  Harboe,  Oslo,  Norway,  f Erna  van  Loghem, 
Amsterdam, Netherlands, g C. Ropartz, Rouen, France, h A. G. Steinberg, Cleveland, Ohio. 
2 of them, viz. Hu. and La., were Negroes. The Gm(a+b--f-)  and Gm(a--b--f+) myeloma 
globulins belonged to the major H  chain class, the We class; the Gm(a--b+f--)  myeloma 
globulins, to the Vi class; and the Gin(a--b--f--) myeloma globulins, to the Vi, the Ge, or 
the Ne class (4). Only myeloma sera containing at least 30 mg/ml of myeloma globulin and 
decreased amounts  of normal 5,-globulin  (probably always below  5  mg/ml)  and  myeloma 
globulin preparations isolated as in previous studies (13,  14) were investigated. 
In addition,  1 myeloma serum from a  Chinese patient was available. The myeloma glob- LARS  MARTENSSON  AND  HENRY  G.  KUNKEL  801 
ulin was  of "yG-type by immunoelectrophoretic criteria. The "y-globulin concentration was 
45 mg/ml as estimated by paper electrophoresis. The staining of the "y-region of the electro- 
phoresis strip, outside the sharp "yrmyeloma band, was much fainter than the corresponding 
region of normal serum strips. Thus, the serum contained about 40 mg/ml myeloma globulin 
and considerably less normal 5"-globulin than sera from healthy persons. 
Anti-Rh Antibodles.--20 anti-Rh sera from European and  2 from American donors were 
selected. Only sera found to make Rh-4- red ceils strongly agglutinable by 1 or another anti-Gm 
were included. The series does not reflect the frequencies of the different Gin types among 
random anti-Rh coats (cf. reference 2); in particular,  Gin(b+)  antibodies are intentionally 
over-represented. 
Normal Sera.--73 Gm(ad-) sera, to be typed with the various Gin(f) reagents, were from 
normal Swedish blood donors. 
C,m Determinations.--Gm determinations of sera and other protein solutions are made with 
an  agglutination-inhibition  test.  Anti-Gin  sera  agglutinate  red  cells coated  with  Gm(d-) 
anti-Rh antibodies. Sera from individuals whose "y-globulin contains the specific determinant 
inhibit the agglutination.  For example, a  Gin(a)  typing system consists of an anti-Gin(a) 
agglutinator and red cells coated with Gm(ad-) anti-Rh antibodies; Gm(ad-) sera inhibit the 
agglutination, while Gm(a--)  sera do not.  The techniques used for Gm typing have been 
described previously (2). 
The myeloma sera and  myeloma globulin preparations  were tested  in series of twofold 
dilutions to determine the inhibitory titers in the different Gm typing systems. The myeloma 
sera and preparations examined contained at least about 6 times as much myeloma globulin 
as normal "y-globulin  (see above). This made it possible to decide by quantitative considera- 
tions whether a certain Gin activity demonstrated in the serum or the preparation should be 
ascribed to the myeloma protein or to the residual normal "y-globulin  (c/. reference 2). This 
distinction was further facilitated by the fact that a myeloma globulin Gm(+) in respect of 
a particular Gm factor has a higher activity per unit protein than the total normal "y-globulin 
of a  Gin(-4-)  serum (of. reference 2).  The procedure used for Gm typing of myeloma globu- 
lins, which was described in greater detail in reference 2, is exemplified by the investigation 
of the Chinese myeloma serum (see Results). 
The normal and the anti-Rh sera were typed in only 1 dilution, 1/10, in order to  econo- 
mize valuable reagents.  The Gin types of anti-Rh sera were  determined  after  absorption 
of the anti-Rh antibodies; 0.5 cc of the 1/10 dilution of the serum was absorbed twice with 
0.2 cc of packed Rhd- red cells at 37°C for 60 minutes. 
The Gm types of incomplete anti-Rh antibodies were determined by direct agglutination 
(Table IV). The antibodies were coated on Rhd- red cells and the coated cells tested with 
the anti-Gin agglutinators. Agglutination is taken to mean that the anti-Rh antibodies carry 
the Gm determinant in question; non-agglutination, that none, or only relatively few, of the 
antibodies carry the determinant. For example (see Table IV), the whole "y-giobulin of serum 
I.M.  is  Gm(ad-bd-f-f-),  whereas  the  anti-Rh  antibody  protein  is,  at  least  largely, 
Gm(a+b-f--).  In the experiment of Table IV one volume of packed O Rhd- red cells was 
coated with 10 volumes of each anti-Rh serum diluted 1/5, or less, for 90 minutes at 37°C. 
The agglutinators used to test the coated cells were diluted according to their titers. 
P,.ESULTS 
Myeloma Globulins.--Table  II gives the Gm types of the Caucasian and the 
2  Negro myeloma  globulins.  The  Gin(b)  specificities,  except b 9 but  including 
b e, b~, b~, b 3, and b* (some  of which may be identical), were found together in 
the same Caucasian Vi type myeloma globulins.  Gm(b  2) and the determinants 802  GM  AND  H  CHAIN  GROUP  SPECIFICITIES  OF  "/G-GLOBULINS 
TABLE II 
Gm  Types  of Sdected  Myeloma  Globulin 
Myeloma  globulins  I  Gm  test  systems* 
i 
Gm(f)  Gm (b) 
H  chain  anti- 
genic  types 
We 
Vi 
(~,~o) 
Ge 
(~) 
Ne 
Designation 
G.S. 
O.L. 
E.S. 
E.H. 
J.A. 
E.P. 
M.P. 
789 
818 
844 
904 
Me 
S,H. 
K.B. 
276 
619 
224 
589 
Ap. 
Fe. 
Man. 
Hu. (Negro) § 
Zu. :H~ 
Sh. 
Vi. 
Ge. 
Ro. 
La. (Negro) 
Ne. 
~a. 
B1. 
Mag. 
Da. 
Gin(a) 
1  3  4  .5  617 
÷ 
+ 
+ 
÷ 
-  ÷÷-!++÷ 
-  +++  + 
-  ÷+÷++ 
-  +++++ 
-  ++++1+ 
-  +++!÷+ 
-  +-+++ 
-  +  +!-+ 
m  _ 
m 
.....  I_  m 
Gm(b 2) 
8 
I  + 
+ 
+ 
+  -i 
+ 
+ 
10  11  13  14  15____  .16a 
-  I 
16b  17  !81119 
u  h 
m  m 
m  _ 
m  _ 
--  m 
m  m 
m  m 
m  i ........ 
_  m 
+i++++1+  +  +++  ++++  +  +  +++ 
+++++~  +  +  +++ 
+i++++  +  +  +++ 
+++++!  +  +  ++ 
+i++++  +  +  ++ 
+++++1  +  +  +!++ 
+1  +~ 
+  ++r  +  +  ++ 
++++-  +  +  + 
+++÷+1  +  +  +++  I 
-I 
!  m 
--i 
* The test systems used are indicated by numbers in the head of the Table. The numbers 
refer to Table I. 
:~ Zu. :H is the paraprotein of a patient with Franklin's disease (15). 
§ The Negro myeloma globulin Hu. was typed clearly negative with anti-Gm(b) Th. and 
with two other anti-GmCo)  reagents (not included in the Table); it was clearly positive with 
the other anti-Gin (b) reagents. 
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identified by 5  anti-Gin(f)  reagents  were as  a  rule found together in  other 
myeloma globulins. 
A few myeloma globnlln~ were exceptional and reacted with some but not 
with other anti-Gm(f) or anti-Gin(b)  reagents. Myeloma globulins J.A.  and 
904 were both negative with 1, but not with the  same, anti-Gm(f); Me. was 
negative with  2  of the anti-Gm(f) reagents.  Myeloma globulin Hu., from a 
Negro patient, was dearly negative with anti-Gm(b  3) Th. but clearly positive 
with  another anti-Gin(b),  identical or related  to  (cf.  11)  anti-Gin(b1).  It is 
noteworthy that among the essentially Gin(f+) myeloma globulins as many 
as 3 lacked the antigenic determinant identified by 1 or another anti-Gin(f), 
whereas only the Negro myeloma globulin gave discordant results with differ- 
ent anti-Gin(b)  reagents,  despite the fact that the experiments on Gm(b+) 
myeloma  globulins  were  more  extensive  than  those  on  Gm(f+)  myeloma 
globulins. 
The paraprotein of the patient Zu. with Franklin's disease was included in 
Table II.  This protein probably corresponds to  Fc  (fast) "r-globulin papain 
fragments (15). It carried all the Gm(b) specificities, except b * but including 
b ~, bO, b~, b 3, b 4, and others, which suggests that they all occur in or close to 
the Fc part of the ~/G-molecule, 
The  (relatively)  homogeneous  myeloma  globulins  were  generally  more 
strongly  inhibitory  than  the  heterogeneous  whole  -r-globulin  from  normal 
individuals positive with respect to the same factor (cf.  reference 2): (a) The 
inhibitory activity of Gin(b-I-) mydoma globulins was 4  to 32 times as high 
as that of the whole -g-globulin in Gm(b-t-) sera from normaN; this difference 
in activity per unit protein between Gm(b-t-) normal and myeloma ~-globu- 
lins was found in all 10 Gin(b) test systems used. (b) The Gin(f-k) myeloma 
globulins, on the other hand, were on the average only about twice as inhibi- 
tory per unit protein as whole 3,-globulin in Gin(f-l-) normal sera. 
The investigation of the Chinese myeloma serum will be described in greater 
detail since the results were essentially different from those obtained with any 
Caucasian myeloma serum. The following paragraph also illustrates how the 
Gm types of the myeloma globulins were determined (cf.  reference 2). 
Table HI gives the results of the Gm determinations of the Chinese myeloma serum. 
Several Caucasian, 3 Japanese, and 3 Eskimo sera of type Gm(a~b-~f-~)  were tested with 
the Gin(a), (b), and  (0 test systems, and they gave closely similar inhibitory titers.  (No 
normal Chinese sera were available.) The Chinese myeloma serum, on the other hand, was 8 
to 16 times more strongly inhibitory in the Gin(a) and (f) systems, but less inhibitory in the 
Gin(b) systems, than the normal sera (Table III). The values for the Gin(a) and the Gin(0 
activities (Table HI) can hardly be accounted for by the normal ~'-globulin; they must be 
ascribed to the myeloma globulin. Since the serum contained about 40 mg/ml of myeloma 
globulin, the Gin(a) and Gin(0 activities (per unit protein) of the myeloma globulin were 
about 2 to 4 times higher than the specific  activities of the tota~ "/-globulin  of normal Gin(a-b) 
and Gm(f-]-)  sera. On the other hand, the Gin(b) (Gm(b  1) and Gm(bS), of. reference 11) titers 
can be ascribed to the residual normal "y-globulin. 804  Gift AND  H  CHAIN GROUP  SPECIFICITIES OF '~G-GLOBULINS 
Accordingly, the ~,G-myeloma globulin  of the  Chinese  serum was grouped 
as Gm(a+f-l-b-),  a  type that has not been found among Caucasian myeloma 
globulins (2, 4, and Table II). 
In view of the importance of this myeloma protein detailed investigation of 
its characteristics  and isolation were carried out. Electrophoresis  experiments 
in various  media  indicated  a  very homogeneous myeloma peak  of slow  mo- 
bility. Both the Gin(a)  and Gin(f)  characters were found associated with this 
peak  utilizing  totally  different  reagents  than  those  used  for  Table  III. The 
myeloma protein was of the We group with lambda type light chains. 
TABLE HI 
Gm Characteristics of 1 Chinese Serum Containing about 40 mg/ml of a 7G-Myelorna Protein 
Test systems (see Table I)  Specific activity of the myeloma serum* 
Gin(a) :  No.  1 
No. 2 
Gin(f):  No. 4 
No. 5 
No. 6 
Gin(b) :  No. 10 
No. 15 
16 
16 
8 
4--8 
8 
½ 
½ 
* The average activity of normal  Gin(-}-) reference sera has arbitrarily,  been given  the 
value 1. Forexample; a normal  Gm(a+) serum as a rulehasa Gin(a) activity close to 1 (<2 
but  >  ~). The Gin(a)  activity of the Chinese myeloma serum was 16, i.e., the inhibitory 
titre was 16 times higher than the average titre of normal Gin(a+) sera. In the two Gin(b) 
test systems, on the other hand, the myeloma serum had lower inhibitory titre than normal 
Gin(b+) sera. 
Anti-Rh Antibodies.--Table  IV gives the Gm types of anti-Rh antibodies.  It 
is  well  established  that  even  if  the  individual  possesses  a  particular  genetic 
determinant  it may be absent  from a  specific antibody in his  serum  (2,  16, 
and others; see Table IV for many examples).  The total 7-globulin comprises 
an extremely large number of different molecules whereas a  specific antibody 
consists  of a  limited,  sometimes  a  small,  number  of molecular  species.  The 
experiments  of Table IV are intended  to test a  hypothesis based on the mye- 
loma  data  above:  the  Gm(f)  and  (b  2)  determinants  are  found  together  in 
certain  molecules and  the rest of the  Gin(b)  determinants  are found together 
in other molecules. 
We find, firstly, that anti-Rh antibodies reacting with 1 anti-Gin(f)  generally reacted with 
the others  (Table IV). AntioRh I.K. is exceptional as it was strongly agglutinated  by aati- 
Gin(f) No. 3, but not by No. 4, 6, or 7. Anti-Gm(b 2) Davis agglutinated  anti-Rh Roehm. LARS  M~RTENSSON  AND  HENRY  G.  KUNKEL  805 
,--  +  ---+ 
l  I  I  I  I  I  I  I  I  ~l +++v~,~l  +  I 
-  +  + 
,,  ,,,,  +,,,  +  ++++ 
+++++++++ 
I  I  I  I  I  I  +  I  I  I  +++++++++ 
I  I +  I  I  I +  ++  I~  +++++++++  -  ~  +++++++++ 
I  I  I  I 
+  ,$Z? 
=  I  I  I  I  I  I  I  I  I  I  I  ~+  I 
+  +~+  =  I  + 
g  ~  I  1  I  I  I  I  I  I  I  I  I  I+++  ++  + 
~  +  +++ 
~  ~  +  +++ 
~  ~7  +  + 
+++  +11111  I  I  I  I  I  I  I  +++++ 
++  ++  +111  I  I  I  I  I  l  I  I  ++++ 
+++++++++++l  t~T  I  I  I  I  I  +  ++++++++++  ~ 
++++++  ++ 
I  I  I  I  I++  +++++  +  ++  I  I  I 
++++++++  I  I  I  I  I  I  I  I  I  I  I 
+++++++++  +++++++++l  i  i  i~l  i  i  i  i  i  l~ 
/-  ,,,++++++++++++  ++++  + 
.  ~[  I  I  ~++++++++++++  ++++  + 
~  ++++++++++  I  I  I  +  I  I  I  I  I  + 
+  ~ 
+ 
+ 
m 
°~ 
.° 
m 
I::I 
+~  ~.~ 806  GM  AND  H  C]~IAIN GROLrP SPECI]?ICITIES  OF  "~G-GLOBULINS 
strongly only when used undiluted. A higher concentration of anti-Gm(b  ~) antibodies might 
have given strong agglutination also of other anti-R.h  coats. But the reactions that could be 
obtained places agglutinator Davis together with the anti-Gin(f) rather than the anti-Gin(b) 
reagents. 
Secondly,  we find that anti-Rh antibodies reacting with  1 anti-Gin(b)  as a  rule reacted 
with all the other anti-Gin(b)  reagents (Table IV). There are a  few exceptions to this rule. 
Some of them are only apparent: the weakest agglutinators, No.  13, 14, and 20, do not give 
visible reactions with anti-R.h  coats that react only weakly with stronger anti-Gin(b) agghi- 
tinators. This does not signify absence of some determinants; it is the finding to be expected 
when only a relatively small proportion of the anti-Rh antibodies are Gin(b+)  (of. reference 
2). The anti-Rh antibodies of serum Vai. constitute a  true exception to the rule: the anti- 
Gin(b)  reagents  15  through  20,  including anti-GmCoa),  (bS), and  (b4), agglutinated  with 
maximal strength whereas the other anti-Gin(b) reagents were non-reactive. The Val. anti-Rh 
protein essentially lacks the part of Gin(b) which is identified by Harboe's original anti-Gin(b), 
by anti-Gm(b~), and by anti-Gm(b  t) (of. reference 11). 
The results on anti-Rh antibodies given in Table IV may be sumruarized as 
follows: the anti-Rh  antibody protein  of Gm(b+f+)  sera was in several in- 
stances  Gm(b+f--)  (2086,  2127,  N.B.,  and  Vai.)  or  Gin(b-f+)  (89,  Reb. 
108,  696,  Tti.,  and  Roehm.).  As a  rule  the various anti-Gm(b)  reagents  (ex- 
cept anti-b ~) reacted with the same antibodies and the same was true for the 
anti-Gm(f)  reagents.  It  should  be  remembered  that  this  series  of  anti-Rh 
sera was selected so that  Gm(b+f--)  anti-Rh  antibodies,  in particular,  were 
over-represented. 
Normal  Sera.--5  anti-Gm(f) reagents (test systems 3 through 7) gave identi- 
cal results when used  to  type 73  Gin(a+)  Swedish sera; 55  of the sera were 
positive and 18 were negative with all 5 reagents.  This indicates  that possible 
variants of the Can e gene that determine only some of these Gin(f) specificities 
must be rare (in the germ cell lines) of Northern Europeans. 
DISCUSSION 
In this and in previous  (2,  4) investigations  no Caucasian myeloma globu- 
lins were positive for more than I of the factors Gm(a), (b), and (f) (Table II); 
myeloma  globulins  are  Gm(a~b--f--),  Gm(a--b-fnu),  Gm(a-b-[-f--),  or 
Gin(a--b-f--),  although  the  total  normal  "y-globulin of most myeloma pa- 
tients  and  healthy  individuals  is  Gm(a-[-b-[-f+)  or  Gm(a-b+f-]-)  (2,  4). 
These observations might be explained by the following hypotheses: there are 
3 distinct genes Gm*, Crm  b, and Gmf; each gene determines its own polypepfide 
chain; individual 7G-molecules contain only one of the 3 types of chains; only 
1 Gm gene is active in a myeloma cell clone (2,  4). The anfi-Gm(b)  reagents 
used in the studies  just referred  to were closely related  to the original  anti- 
Gm(b)  of Harboe  (8),  which probably corresponds  to  (cf.  reference  11)  the 
anfi-Gm(b~)  of Ropartz et al.  (9)  and the anti-Gm(b 1) of Steinberg and Gold- 
blum (10). In the present investigation many other anfi-Gm(b)  reagents were 
included,  e.g. anti-Gm(b~),  (b~),  (b~), (b3), and  (b*), which in non-Caucasians 
give results very different from Harboe's anti-Gin(b)  (9-11). LARS  ~RTENSSON  AND  HENRY  G.  KUNKEL  807 
The association between all the Gin(b) specificities, except (b~), in the same 
Caucasian Vi  type myeloma globulins  (Table  II)  suggests that they are  all 
attributes of the polypepfide chain determined by the gene Gm  b at the Vi locus. 
For analogous reasons the data suggest that the  Gin(f) and the Gm(tP)  de- 
terminants are  attributes of the polypeptide chain determined by the gene 
Gm  f at the We locus.  Since many individuals in non-Caucasian populations 
lack some, but not other, Gin(b) specificities (9-11), there probably exist alleles 
at the Vi locus that are similar or identical with the ordinary Caucasian C-m  s 
gene in one segment but different in another (cf. reference 11). 
All the Gin(b) specificifies (except b 2) appear to depend on the Fc pieces of 
H  polypeptide chains. This was initially demonstrated for Gm(b0 by tiarboe 
a  al.  (17) and by Franklin a  al.  (18).  Steinberg and Polmar (19) found that 
(bs), and (b*) (but not b ~) are also recovered in the Fc fragments after papaln 
digestion. All  10  anti-Gin(b)  reagents of this  study reacted with the para- 
protein of a patient, Zu., with Franklin's disease (Table II). 
The anti-Rh antibodies of a given serum, as a rule, reacted with all or none 
of the anti-Gin(b)  (except anti-b~),  and with all or none of the anti-Gin(f) 
reagents  (Table  IV).  These  findings support  the  conclusions drawn on  the 
basis of the myeloma data:  the  Gin(b)  and  (f)  determinants, which are in- 
herited together in Caucasians, are carried by 2 categories of "yG-molecules. 
The  1 category contains a  polypepfide chain determined by the Gm  b gene; 
the other category a chain determined by the closely linked Gm  f gene. When a 
major proportion of the anti-Rh antibodies of a  serum belongs to 1 of the 2 
types,  then  the  antibodies  will  appear  Gm(b+f-)  or  Gin(b-f+)  (Table 
IV). In other anti-Rh sera the 2 types of antibodies occur in amounts of the 
same order of magnitude. Both will then occupy a  significant proportion of 
the Rh sites of the red cells  and the anti-Rh protein is typed Gm(b+f+) 
(Table IV). 
The  results  both  on myeloma globulins and  anfi-Rh antibodies  strongly 
support the view that Gin(b2),  formerly called Gm(b  w)  (20),  and Gin(f) are 
closely related.  Steinberg and Polmar  (19)  felt that  Gm(b  ~)  and  Gin(f)  are 
identical and based  this opinion on genetic population and papain digestion 
studies.  Fudenberg  has  observed  that  the  anti-Gm(b  2)  and  an  anti-Gin(f) 
often typed the  same myeloma globulins as positive  (21).  It  appears  that 
Gm(b  2) is not carried by the same molecules as the other Gin(b) specificities, 
and that it is not determined by a gene at the same locus as Gin(b). This, we 
think,  should be  reflected in  the  nomenclature.  Therefore  the  designations 
G~  f, for the gene, and Gin(f), for the antigenic characteristics, are retained 
here. 
Exceptional myeloma globulins and anti-Rh proteins reacted with some but 
not  with  other  anti-Gin(b)  or  anti-Gin(f)  reagents.  2  explanations  of  this 
phenomenon will be considered: (a) The individual has inherited a gene partly 
different from the ordinary Crm  b or Gm  f. (b) The individual has inherited the 808  GM  AND  H  CHAIN  GROUP  SPECLFICITIES  OF  '~G-GLOBULINS 
ordinary C-m  b or Gm  f gene. But the myeloma or anfi-Rh forming cells  have 
been modified during ontogenesis so that the protein lacks certain of the ex- 
pected genetic determinants. For example, part  of the gene may have been 
lost or altered (cf. 22). 
The former explanation is applicable to the anti-Rh antibodies of sermn Vai. 
(Table IV). They contain the product of C-m  sb, a gene that is probably partly 
identical with,  and partly different from, the ordinary Caucasian Con  b gene 
(11). The myeloma protein Hu. most likely contains the product of still another 
allele at  the  Vi  locus; it lacked a  Gm(b  8)  determinant and represented  the 
only Vi type protein from a Negro. 
3 of the Gm(f~) myeloma globulins and apparently also the I.K. anti-Rh 
protein were negative with 1, 2, or 3 of the anti-Gin(f) reagents. It is possible 
that each of these 4 individuals has inherited a  different variant of the C-m  f 
gene identified by our anti-Gin(f) reagents.  However,  the results on normal 
sera suggests that such variant Gm  f genes, if they exist, are rare in (the germ 
cell  lines of)  Northern  Europeans.  The possibility is not ruled out that the 
ordinary Gm  f gene or some other component of these myeloma and anfi-Rh 
forming cells has been altered during ontogenesis. If so, the alteration affects 
the structure of that part of the "rG-molecule that carries the antibody com- 
bining site; Gin(f) specificities are recovered in the Fab  (Slow)  papain frag- 
ments (23-25,  19). 
One Chinese 3,G-myeloma globulin, the only one available, was found to be 
Gm(a-I-f+b--).  This type has not been encountered among Caucasian mye- 
loma globulins, all of which have been grouped positive for only 1 or for none 
of the factors Gm(a), (b), and (f) (2, 4, and Table II). The data available might 
be  explained by  the  hypothesis that,  in  Caucasians,  anfi-Gm(a)  and  anti- 
Gin(f) identify 2 genes at the We locus, called Crm  b and Crt#, and that Gr# is 
generally coupled with the gene Gra  b at the  Vi locus. On the other hand, in 
some Chinese populations about 90 per cent of the individuals are Gm(aq-fq-) 
(3,  10), which indicates that both factors can be determined by 1 gene or by 2 
genes on the same chromosome (cf. reference 2).  Gin(a) and Gm(f) specificities 
are found in different "},-globulin  papain fragments; Gin(a) in Fc (Fast) (17-19, 
24,  25)  and  Gin(f)  in Fab  (Slow)  fragments (23-25,  19).  This suggests that 
Gm(a) depends on an amino acid sequence in 1 half and Gin(f) on a sequence 
in the other half of the H polypeptide chains. Therefore the Gin(a) and Gin(f) 
antigenic specificities are probably not determined by homologous gene seg- 
ments. On this view, a Gm  af gene could arise from Gm  ~ and Gm  f, for example, 
by intragemc crossing-over, and the Gm(aq-fq-b--) Chinese myeloma globulin 
of this study may contain a  polypeptide chain determined by a  Gm  af gene. 
Consideration should also be given to the possibility that the 2 portions of the 
H chain at which the Gm(a) and Gin(f) specificities are found might represent 
separate polypeptide chains. This possibility has been raised by a  number of LAIRS  M~RTENSSON  AND  I~.NRY  O.  KU'NK.EL  8O9 
investigators  (15,  26)  although  all  efforts  to  effect a  separation  have been 
unsuccessful. 
Since the H  polypeptide chains of the We and of the Vi classes of ,/G-im- 
munogiobulin are  antigenically closely related,  the genes at  the  2  loci must 
have  many  nucleotide  sequences  in  common.  PhylogeneticaUy  these  2  loci 
may  have  arisen  through  duplication  and  subsequent  differentiation  of  1 
ancestral  immunoglobulin  H  chain  gene.  Evidence  in  the  mouse  indicates 
close linkage between  structural  genes for  ,/A-  and ,/G-H chains  (27).  This 
suggests that additional loci determining H  chains of immunoglobulins may be 
clustered in the same chromosomal region as the We and  Vi loci. It is of in- 
terest to note that the partial homology between the genes at the various loci 
might lead to displaced synapsis and consequent unequal  crossing-over. As a 
result chromosomes with supernumerary H  chain loci, and others with missing 
loci, would arise. Nance (28) and Smithies (29) have suggested that the thalas- 
semias and related  disorders of hemoglobin production  might be due  to un- 
equal crossing-overs involving the structurally similar/~, %  and ~ loci.  Simi- 
larly, deficient and duplicated complexes of H  chain genes might account for 
aberrant patterns of immunoglobulin synthesis. 
SUM'MARy 
Isolated myeloma proteins and anti-Rh antibodies were utilized  for determination 
of  the  distribution  among the ,/-globulin  molecules  of various  Gin(b)  and Gm(f) 
determinants.  All  of  these genetic factors are as a  rule inherited  together in  Cau- 
casians,  but not in other races.  The Gin(b)  determinants,  except (b2), were found 
together in the same Caucasian myeloma globulins  of the Vi H  chain group, which 
never carried Gin(f)  or (b2). The Gin(f)  and  (b  ~) determinants were found together 
in other myeloma globulins,  of the We group. Anti-Rh antibody molecules appeared 
to be similar  to myeloma molecules in these respects.  A few myeloma proteins  and 
anti-Rh antibodies were encountered which  reacted with some but not other  anti- 
GmCo) or anti-Gm(f) reagents; the only available Vi type myeloma protein from a 
Negro, specifically lacked the Gm(b  8) factor. 
The observations might be explained  by the following hypothesis: In Caucasians 
with the common C,~ C-m~ gene complex the Gmfo) antigenic determinants, except 
(b2), co-occur in certain molecules, which contain a polypeptide chain determined by 
the Ccm  ~ gene; the Gin(f)  and  Co  *)  determinants co-occur in other molecules,  which 
contain a polypeptide chain determined by the Crmf gene. Individuals that lack some 
Gin(b) or Gm(f) determinants most likely have a gene partly different  from Ccm  b or 
Gin1. 
The value of studies with myeloma proteins from individuals of different racial 
groups was apparent from this  study.  One  myeloma protein from a  Chinese  was 
unique in that it was both Gm(a+) and Gm(f+). 
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